Repligen (NASDAQ: RGEN) reported Q3 EPS of $0.04, in-line with the analyst estimate of $0.04. Revenue for the quarter came in at $15.3 million versus the consensus estimate of $15.6 million.

Repligen sees FY2014 revenue of $60-62 million, versus prior guidance of $59-62 million and the consensus of $0.28 million.

For earnings history and earnings-related data on Repligen (RGEN) click here.